EVEROLIMUS AS THE ONLY COMPONENT OF LONG-TERM MAINTENANCE IMMUNOSUPPRESSION AT LIVER TRANSPLANT RECIPIENTS

被引：0
|
作者：
Salienko, Anastasia [1 ,2 ]
Syutkin, Vladimir E. [1 ]
Novruzbekov, Murad [2 ]
机构：
[1] Sklifosovsky Emergency Med Inst, Liver Transplant Dept, Moscow, Russia
[2] Sklifosovsky Emergency Med Inst, Moscow, Russia
来源：
HEPATOLOGY | 2021年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1478
引用
收藏
页码：877A / 878A
页数：2
相关论文
共 50 条
  • [21] Potencial Antifbibrotic Effect of Long-Term Everolimus Based Immunosuppression in HCV Positive Liver Transplant Patients
    Dopazo, C.
    Bilbao, I.
    Castells, L.
    Sapisochin, G.
    Campos, I.
    Lazaro, J. L.
    Caralt, M.
    Charco, R.
    TRANSPLANTATION, 2012, 94 (10) : 48 - 48
  • [22] In Vitro Immune Cell Monitoring as a Guide for Long-Term Immunosuppression in Adult Liver Transplant Recipients
    Jwa, Eunkyoung
    Hwang, Shin
    Kim, Nayoung
    Song, Gi-Won
    Jung, Dong-Hwan
    Ahn, Chul-Soo
    Tak, Eunyoung
    Moon, Deok-Bog
    Kim, Ki-Hun
    Ha, Tae-Yong
    Park, Gil-Chun
    Lee, Sung-Gyu
    TRANSPLANTATION, 2016, 100 : S228 - S228
  • [23] Immunosuppression minimization is safe and associated with good long-term success in pediatric recipients of liver transplant
    Chapin, Catherine A.
    Whitehead, Bridget
    Shakhin, Victoria
    Taylor, Sarah A.
    Kriegermeier, Alyssa
    Mohammad, Saeed
    Alonso, Estella M.
    LIVER TRANSPLANTATION, 2024, 30 (07) : 707 - 716
  • [24] Approaching operational tolerance in long-term pediatric liver transplant recipients receiving minimal immunosuppression
    VarelaFascinetto, G
    Treacy, SJ
    Vacanti, JP
    TRANSPLANTATION PROCEEDINGS, 1997, 29 (1-2) : 449 - 451
  • [25] Impact of immunosuppression minimization and withdrawal in long-term hepatitis C virus liver transplant recipients
    Tommaso Maria Manzia
    Roberta Angelico
    Paolo Ciano
    Jon Mugweru
    Kofi Owusu
    Daniele Sforza
    Luca Toti
    Giuseppe Tisone
    World Journal of Gastroenterology, 2014, (34) : 12217 - 12225
  • [26] Risks and benefits of weaning immunosuppression in liver transplant recipients: Long-term follow-up
    Mazariegos, GV
    Reyes, J
    Marino, I
    Flynn, B
    Fung, JJ
    Starzl, TE
    TRANSPLANTATION PROCEEDINGS, 1997, 29 (1-2) : 1174 - 1177
  • [27] In vitro immune cell monitoring as a guide for long-term immunosuppression in adult liver transplant recipients
    Jwa, Eunkyoung
    Hwang, Shin
    Lee, Sung-Gyu
    Ha, Tae-Yong
    Ahn, Chul-Soo
    Park, Gil-Chun
    Kim, Jee-Yeon
    Sung, Min-Kyu
    TRANSPLANTATION, 2016, 100 (07) : S502 - S502
  • [28] Impact of immunosuppression minimization and withdrawal in long-term hepatitis C virus liver transplant recipients
    Manzia, Tommaso Maria
    Angelico, Roberta
    Ciano, Paolo
    Mugweru, Jon
    Owusu, Kofi
    Sforza, Daniele
    Toti, Luca
    Tisone, Giuseppe
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (34) : 12217 - 12225
  • [29] Benefits and Risks of Introduction of Everolimus in Long-Term Kidney Transplant Recipients
    Asai, Toshihiro
    Tanaka, Hisao
    Nishikawa, Noriaki
    Hasaka, Tomohiro
    Kitamoto, Koichiro
    Ishii, Keiichi
    Kamikawa, Sadanori
    Sugimoto, Toshikado
    Kim, Taku
    Kumada, Norihiko
    TRANSPLANTATION, 2017, 101 (05) : S14 - S14
  • [30] Long-term pharmacokinetics of the metabolites of everolimus and cyclosporine in renal transplant recipients
    Kirchner, GI
    Mueller, L
    Winkler, M
    Loss, M
    Roechte, F
    Deters, M
    Christians, U
    Kaever, V
    Klempnauer, J
    Sewing, KF
    Manns, MP
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (06) : 2233 - 2234
12345